0002048500-26-000008.txt : 20260603 0002048500-26-000008.hdr.sgml : 20260603 20260603174313 ACCESSION NUMBER: 0002048500-26-000008 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Beta Bionics, Inc. CENTRAL INDEX KEY: 0001674632 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 475386878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-42491 FILM NUMBER: 261062321 BUSINESS ADDRESS: STREET 1: 11 HUGHES CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-427-7785 MAIL ADDRESS: STREET 1: 11 HUGHES CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Beta Bionics, Inc DATE OF NAME CHANGE: 20160513 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Mensinger Mike CENTRAL INDEX KEY: 0002048500 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O BETA BIONICS, INC. STREET 2: 11 HUGHES CITY: IRVINE STATE: CA ZIP: 92618 144 1 primary_doc.xml 144 0002048500 XXXXXXXX LIVE 0001674632 BETA BIONICS, INC. 001-42491 11 HUGHES IRVINE CA 92618 949-427-7785 Michael R. Mensinger Officer Common Stock Morgan Stanley Smith Barney LLC
1 New York Plaza New York NY 10004
4378 55994.62 44561695 06/02/2026 NASDAQ Common Stock 06/01/2026 Restricted Stock Units vesting under registered plan Issuer N 4378 06/01/2026 Compensation for services rendered to Issuer N Michael Mensinger
c/o Beta Bionics, Inc. 11 Hughes Irvine CA 92618
Common Stock 03/02/2026 1064 13152.74 This is a sell-to-cover transaction for taxes owed related to recent vesting of stock unit awards granted by the Issuer. 06/03/2026 /s/ Stephen Feider, Attorney-in-Fact EX-24 2 ex24-06032026_090615.htm ex24-06032026_090615.htm



POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Stephen Feider, Kevin Meinert and Alison Kincade signing individually, the undersigned’s true and lawful attorneys-in fact and agents to:

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of Beta Bionics, Inc. (the “Company”), Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules thereunder, Form 144 and a Form ID, Uniform Application for Access Codes to File on EDGAR;

(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to execute such Forms 3, 4 or 5, Form 144, or Form ID (including any amendments thereto) and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 or Form 144 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company or Cooley LLP, as applicable.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of December 27, 2024.


/s/ Mike Mensinger__________________

Mike Mensinger